Project description
A pioneering screening tool for early detection of bladder cancer could save millions
The difference between early and late diagnosis of cancer can mean the difference between life and death. Unlike a routine PAP test for cervical cancer or a colonoscopy for colon cancer, there is currently no effective screening tool for bladder cancer and late diagnosis can have lethal consequences. VISIOCYT has developed a simple software solution that evaluates standard clinical cytology slides. A proprietary method for preparation, staining and observation of cells is coupled with an image processing algorithm to detect the presence of localised fluorescence associated with malignancy. Deep learning algorithms allow the software to learn from the data without being explicitly programmed. EU funding is supporting commercialisation of this reproducible and high throughput technology for early bladder cancer detection.
Fields of science
Programme(s)
Funding Scheme
SME-1 - SME instrument phase 1Coordinator
35000 Rennes
France
See on map